FDA News

FDA grants breakthrough therapy designation to Tafinlar-Mekinist combination for adjuvant treatment of BRAF-positive melanoma

October 23, 2017
The FDA granted breakthrough therapy designation to the combination of dabrafenib and trametinib for adjuvant therapy of patients with stage III…

In the Journals

Post-transplant squamous cell carcinoma incidence declined in recent years

October 20, 2017
There has been a consistent decline in squamous cell carcinoma post-transplant among organ transplant recipients in Norway since the 1980s, according…

In the Journals

One in five young women dependent on indoor tanning

October 19, 2017
Data from a recent survey demonstrate indoor tanning dependence was linked with symptoms of depression and beliefs about physical appearance. The…

FDA News

FDA grants priority review to Opdivo for resected, high-risk melanoma

October 17, 2017
The FDA granted priority review to nivolumab for the treatment of patients with melanoma who are at high risk for disease recurrence following…

Meeting News

Residual atypical intraepidermal melanocytic proliferation may predict melanoma diagnosis

October 12, 2017
Increasing proportions of atypical intraepidermal melanocytic proliferation on various parts of the body may increase the likelihood of a diagnostic…

Meeting News

Upgrade to more aggressive subtype common in Mohs surgery patients

October 11, 2017
Patients undergoing Mohs micrographic surgery for aggressive subtypes of nonmelanoma skin cancer were frequently upgraded to a more aggressive…

USPSTF: Evidence lacking to determine benefits, harms of skin cancer self-exams

October 10, 2017
In a draft recommendation statement, the U.S. Preventive Services Task Force said there is insufficient evidence to determine if the benefits…

In the Journals

Experts recommend reviewing prior authorization policy for skin biopsies

October 10, 2017
Research is needed to address the utility and impact of prior authorization for skin biopsies, according to three authors of a recent opinion paper…

In the Journals

Medicaid patients experience longest delays in melanoma surgery

October 4, 2017
Patients with melanoma were more likely to experience delays in surgery if they were insured by Medicaid compared with Medicare or private insurance…

In the Journals

Pembrolizumab superior to ipilimumab in advanced melanoma

October 3, 2017

Video

Baseball Hall of Famer Mike Schmidt promotes sun protection, skin cancer awareness

September 28, 2017
Mike Schmidt, a Major League Baseball Hall of Famer who played 17 seasons with the Philadelphia Phillies, received a stage III melanoma diagnosis in…

Video

Baseball Hall of Famer: Physician’s confidence affects patients

September 26, 2017
Mike Schmidt, whose success during his 17-year career with the Philadelphia Phillies earned him induction into the National Baseball Hall of Fame…

Video

Baseball star who survived melanoma ‘suffering’ from lack of sunscreen use

September 22, 2017
Mike Schmidt, a former member of the Philadelphia Phillies widely considered to be the greatest third baseman in Major League Baseball history…

In the Journals

Rule of three may be more effective than rule of two in melanoma testing

September 21, 2017
Compared with the rule of two for detecting melanoma, the rule of three was more effective in identifying genetic risk factors for the disease in a…

Mike Schmidt, baseball great and melanoma survivor, promotes importance of ‘cancer game plan’

September 21, 2017
Mike Schmidt is widely considered the greatest third baseman in Major League Baseball history. His 548 career home runs rank 16th all time. The other…

Video

Baseball Hall of Famer Mike Schmidt ‘paying it forward’ through campaign to support patients with cancer

September 21, 2017
Mike Schmidt always felt a sense of invincibility as a professional athlete. That changed in 2013, when Schmidt — a member of the National…

In the Journals

Delayed Mohs surgery does not impact complication risk

September 15, 2017
The timing of Mohs micrographic reconstructive surgery had no impact on infection risk or flap failure, according to recent findings. The researchers…

Novel AI imaging approach yields improved skin cancer diagnosis

September 13, 2017
A novel imaging approach using artificial intelligence was associated with improved detection of parameters associated with melanoma, according to…

FDA News

FDA accepts application for binimetinib-encorafenib combination for BRAF-mutated melanoma

September 13, 2017
The FDA accepted for review new drug applications that seek the use of the COMBO450 regimen to treat patients with BRAF-mutant advanced…

Meeting News

Adjuvant vemurafenib confers clinical benefit in resected BRAF V600-positive melanoma

September 11, 2017
MADRID — Adjuvant vemurafenib conferred substantial clinical benefit to patients with completely resected stage IIC to stage IIIB BRAF

Healio Jobs